Hyaluronan and CD44 expression in minor salivary gland tumors

Oral Diseases

Volumn 4, Issue 4, 1998, Pages 241-247

  Xing, R ^a   Regezi, Joseph A ^b,d   Stern, M ^a   Shuster, S ^c   Stern, R ^c  

^a Dept Oral and Maxillofacial Surg ^*  (United States)

^b SHOWA UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD44; Hyaluronan; Salivary gland tumor

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; MONOCLONAL ANTIBODY;

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOMA; ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER INVASION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; MINOR SALIVA GLAND; PRIORITY JOURNAL; SALIVARY GLAND TUMOR;

EID: 0032438398     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.1998.tb00287.x     Document Type: Article

References (26)

1. Allerton SE, Beierson JW, Powars SR et al (1970). Abnormal extracellular components in Wilm's tumor. Cancer Res 30: 679-683.
2. Aruffo A, Stamenkovic I, Melnic M et al (1990). CD-44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303-1313.
3. Attanoos RL, Webb R, Gibbs AR (1997). CD44 expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinoma. Histopathology 30: 260-263.
4. Azumi N, Underhill CB, Kagan E et al (1992). A novel biotinyl-ated probe specific for hyaluronate. Am J Surg Pathol 16: 116-121.
5. Culty M, Shizari M, Thompson EW et al (1994). Binding and degradation of hyaluronan by human breast cancer lines expressing different forms of CD44: correlation with invasive potential. J Cell Physiol 160: 275-286.
6. Dietrich A, Tanczos E, Vanscheidt W et al (1997). High CD44 surface expression on primary tumors of malignant melanoma correlates with increased metastatic risk and reduced survival. Eur J Cancer 33: 926-930.
7. Fries H, Elsaser HP, Mahlbacher V et al (1994). Localization of hyaluronate (HA) in primary tumors and nude mouse xenog-rafts of human pancreatic carcinomas using a biotinylated HA-binding protein. Virchows Archiv 424: 7-12.
8. Herrlich P, Pals S, Ponta H (1995). CD44 in colon cancer. Eur J Cancer 31A: 1110-1112.
9. Horai T, Nkamura N, Tateishi R et al (1981). Glycosaminoglycans in human lung cancer. Cancer 48: 2016-2021.
10. Kaufmann M, Heider KH, Sinn HP et al (1995). CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345: 615-619.
11. Kimata K, Honma Y, Okayama M et al (1983). Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential. Cancer Res 43: 1347-1354.
12. Knudson W, Biswas C, Li XQ et al (1989). The role and regulation of tumor-associated hyaluronan. Ciba Found Symp 143: 150-159.
13. Kojima J, Nakamura N, Kanatani M et al (1975). The glycosaminoglycans in human hepatic cancer. Cancer Res 35: 542-547.
14. Laurent TC, Fraser RE (1992). Hyaluronan. FASEB 6: 2397-2404.
15. Lewin DL (1996). New reports blur image of promising metastasis marker. J NIH Res 8: 24-26.
16. Pauli BU, Knudson W (1988). Tumor invasion: a consequence of destructive and compositional matrix alterations. Human Path 19: 628-639.
17. Penno MB, August TJ, Baylin SB et al (1994). Expression of CD44 in lung tumors. Cancer Res 54: 1381-1387.
18. Roboz J, Greaves J, Silides D et al (1985). Hyaluronic acid content of effusions as a diagnostic aid for malignant mesothelioma. Cancer Res 45: 1850-1854.
19. Tengblad A (1979). Affinity chromatography on immobilized hyaluronate and its application to the isolation of hyaluronate binding properties from cartilage. Biochem Biophys Acta 578: 281-289.
20. Toole BP, Biswas C, Gross J (1979). Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc Natl Acad Sci USA 76: 6299-6303.
21. Toole BP (1981). Glycosaminoglycans in morphogenesis. Cell Biology of Extracellular Matrix. ED Hay, ed. New York, Plenum Press, pp 259-294.
22. Toole BP (1990). Hyaluronan and its binding proteins, the hyaladherins. Curr Opin Cell Biol 2: 839-844.
23. Turley EA, Torrance J (1985). Localization of hyaluronate and hyaluronate-binding protein on motile and non-motile fibreblasts. Exp Cell Res 161: 17-28.
24. Underhill CB (1992). CD44: The hyaluronan receptor. J Cell Sci 103: 293-298.
25. Wang C, Tammi M, Guo HT et al (1996). Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am J Pathol 148: 1861-1869.
26. Zhang LR, Underhill CB, Chen LP (1995). Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res 55: 428-433.